Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

This publication has 112 references indexed in Scilit:

• Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid Bacteria
  Clinical and Vaccine Immunology, 2003
• Crohn's disease
  European Journal of Gastroenterology & Hepatology, 2003
• Regional and host specificity of colitis in mice monoassociated with different non-pathogenic bacteria
  Gastroenterology, 2003
• Probiotic inhibition of the entry of enteroinvasive E. coli into, human intestinal epithelial cells involves both Rho-dependent and -independent pathways
  Gastroenterology, 2003
• Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment
  The Esophagus, 2003
• Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease
  American Journal of Gastroenterology, 2002
• Antibiotics in Crohn's disease
  Gut, 2001
• Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine
  Gastroenterology, 2001
• Open label trial of oral clarithromycin in active Crohn’s disease
  Alimentary Pharmacology & Therapeutics, 2000
• Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis
  Digestive Diseases and Sciences, 1994